Herpes simplex virus type 2 wild-type and 13 temperature-sensitive mutants have been examined for their ability to be recovered from latently infected Biozzi mice. After inoculation into the rear footpad, virus could be recovered from both the dorsal root ganglia (DRG) and the footpad (FP) at the site of inoculation (wt, ts 1, ts 2, ts 4, ts 6, ts 7 and ts 8), or from the DRG only (ts 11 and ts 13), or from FP only (ts 3, ts 9, ts 12). Two mutants (ts 5 and ts 10) have not been recovered from either site. Both DNApositive and DNA-negative mutants have been shown to be capable of establishing latent infection.
Following a primary infection in man, herpes simplex virus (HSV) usually establishes latency, from which it may periodically reactivate and release virus; this can result in overt clinical disease. HSV genetic information persists in sensory ganglia both in man and in experimental animals, and after explantation of ganglia followed by culture in vitro the latent virus can be reactivated (Stevens & Cook, 1971; Stevens, 1975; Bastian et al., 1972; Barringer, 1975) .
HSV-1 temperature-sensitive (ts) mutants have been used to probe the mechanism of latency, and differences in ability to be recovered from latency have been described (Lofgren et al., 1977; Watson et al., 1980; Clements & Subak-Sharpe, 1983) . In this paper we describe for the first time the ability of HSV-2 ts mutants to be recovered from the latent state in mouse dorsal root ganglia (DRG). In addition, we have been able to recover HSV-2 from another tissue, the footpad (FP) at the site of inoculation 3 months or more after infection.
HSV-2 wild-type (wt) virus and a set of 13 ts mutants were used (Timbury, 1971 ; Halliburton & Timbury, 1973 , 1976 to inoculate 3-to 4-week-old Biozzi high antibody responder strain mice of both sexes via the rear FP (10 s to 106 p.f.u.). No significant difference in response between males and females was found. It is relevant that the mouse body core temperature (38.5 °C) is non-permissive for the ts mutants used. The FP may be somewhat below the core temperature when the mice are active; however, when they are closely packed asleep in the nest, the FP temperature is probably at, or very close to, that of the core. No animal died or became paralysed following infection of Biozzi mice with the HSV-2 wt and ts mutants at the doses indicated in Table 1 . Some mice showed slight FP swelling immediately after the initial inoculation, but no swelling or symptoms of active infection were noted subsequently.
At least 3 months after primary infection (when the mice were asymptomatic), the animals were killed using chloroform. Nine ipsilateral (one sacral, six lumbar, two thoracic) and two contralateral DRG were rapidly dissected out and explanted under aseptic conditions. In addition, FP tissue from both the left and the right rear limbs was also explanted from each mouse and grown as organ cultures in vitro at 31 °C. In 16 cases out of a total of 199, the explanted FP became contaminated during culture and had to be discarded. Explant cultures of individual ganglia and FP tissue were maintained in 150 gl Eagle's minimum essential medium (Glasgow modified) supplemented with 50~ foetal calf serum, penicillin (100 units/ml), streptomycin (100 gg/ml), gentamicin (25 gg/ml) and nystatin (25 units/ml) in microtitre plates. Released virus was t On leave of absence from University of Baghdad, Iraq.
0022-1317/83/0000-5499 $02.00 © 1983 SGM (0) detected by screening the supernatant on semi-confluent BHK cells grown in microtitre plates. On several occasions, an FP was divided into two: one half was incubated as above, and the other homogenized and immediately screened. At no time was virus found in the homogenate, although virus reactivated from the cultivated half-FP in several cases. The screening procedure was carried out daily for the explanted FP cultures and twice weekly for DRG. Recovered viruses were checked for growth on BHK C13 cells both at 31 °C and at 38.5 °C (the permissive and non-permissive temperatures). A mouse in which either the FP and/or any ganglion released virus on one or more occasions was scored as positive. The first screening always took place within 24 h after explantation. As no mice died after inoculation of l0 s p.f.u, of HSV-2 strain HG52 wt virus, the Biozzi high antibody responder strain falls into the group of mouse strains relatively resistant to acute infection with HSV to which, for example, C57BL/6 mice also belong (Lopez, 1975; Kirchner et al., 1978; Clements & Subak-Sharpe, 1983 ). Details of comparative work using HSV-1 and HSV-2 with five mouse strains will be published in due course.
Virus was never detected in the supernatant from explanted DRG earlier than the 6th day after dissection. The majority of HSV-2 reactivants from explanted ganglia first appeared between day 7 and 14 and the latest time at which virus was first detected was 24 days after DRG explantation. To our surprise, we reproducibly obtained virus reactivation also from FP explants of mice infected with HSV-2. The FP cultures never shed virus before the 10th day after explantation and on one occasion not before 42 days after explantation. No virus has ever been detected in tissue homogenates immediately after explantation, which is in keeping with other reports (Cook & Stevens, 1976; Hill & Blyth, 1976) . At the doses of HSV used in the present study, virus was never recovered from the left DRG or the left FP, contralateral to the site of inoculation. The virus that reactivated from mice initially infected with a ts mutant was checked and in every case proven to have retained the ts phenotype. Using the restriction enzymes BamHI, BglII, HindIII, KpnI and EcoRI (Lonsdale, 1979) , the DNA fragment profiles of reactivated viruses were compared to the profiles of the virus used for initial infection. In every case the profiles were shown to be unchanged.
As can be seen from Table 1 , HSV-2 wt virus was recovered with high efficiency from the DRG but only infrequently from the FP; the efficiency of recovery was dose-dependent. Two HSV-2 mutants, ts 5 and ts 10, have not been recovered following explantation either from DRG or from the FP; mutants ts 3, ts 9 and ts 12 have only been recovered from explanted FP, while mutants ts 11 and ts 13 have been recovered from DRG only. The remaining HSV-2 mutants were all recoverable both from DRG and FP, but whilst ts 1, ts 6 and ts 7 were obtained from either site with approximately equal frequency, ts 2, ts 4 and ts 8 were much more frequently reactivated from the DRG. have not been recovered from DRG. t Mutants ts3 (16 mice), ts5 (12), ts9 (11), ts 10 (13) and ts 12 (14) :~ No virus was ever recovered from the left side DRG.
The distribution of ganglia from which HSV-2 was recovered was not the same for all the latency-positive mutants. Mutants ts 2 and ts 4 were, like wt, recovered from a number of ganglia, some of which would not be expected to innervate the footpad directly, whereas the other mutants were shed from only one or two of the ganglia innervating the footpad ( Table 2) .
The above results suggest the following tentative conclusions. (i) Non-recovery of HSV-2 mutants ts 5 and ts 10 from either site suggests that these mutants are deficient in functions either necessary for the establishment or maintenance of latency in Biozzi mice, or for the ability to reactivate upon explantation. (ii) The recovery of some HSV-2 mutants (ts 3 and also ts 9 and ts 12) only from the explanted FP suggests that HSV-2 can become latent in tissues other than, and apparently independent of, the DRG. (iii) The recovery of the HSV-2 mutants ts 11 and ts 13 only from DRG supports the notion of independent latency in FP and DRG. (iv) Only four mice produced virus both from the FP and from DRG following explantation, one infected with HSV-2 wt and one each with ts 4, ts 7 and ts 8. This is in keeping with the hypothesis that HSV-2 can produce latent infection independently at the two sites. (v) The observed differences in reactivation of HSV-2 ts mutants from DRG and/or FP, and the apparent differences between ts mutants in recoverability, are evidence that the genetic control of the ability of HSV to produce latent infection is not simple and at least in part due to several virus gene functions. It is relevant in this context that both DNA-positive and DNA-negative mutants were shown to induce latent infection.
All the reactivants had retained the ts phenotype which excludes reversion to the wt, temperature-resistant phenotype as an explanation for the recovery of some of the ts mutants. It is not possible to exclude that some leakiness allowing replication may have occurred, particularly in the mouse FP which may not always have been at the mouse core temperature. Any leak-through would tend to increase the capacity for viral gene expression and therefore favour the establishment of latency. These considerations can not help to explain the nonrecovery of mutants ts 5 and ts 10.
There is good evidence that the viral genome is latent within the sensory neurones of DRG (McLennan & Darby, 1980) , but recovery from central nervous tissue, autonomic ganglia and the adrenal gland has also been reported (Cook & Stevens, 1976; Nesburn et al., 1972; Warren et al., 1978; Price et al., 1975; Knotts et al., 1973) . Skin explant cultures from the sites in man at which HSV recurrences had been observed did not yield virus (Rustigan et al., 1966) . However, HSV has been shown to be present in peripheral tissues of latently infected animals under some circumstances. Scriba (1976 Scriba ( , 1977 isolated HSV-1 and HSV-2 from the site of inoculation of latently infected guinea-pigs (FP and vagina). Donnenberg et al. (1980) have also isolated HSV-2 from guinea-pig FP. Hill et al. (1980) reported the isolation of HSV-1 from the ear skin (the site of inoculation) in 8 ~o of latently infected mice in the absence of clinical lesions. Recurrent HSV in patients with 'blow-out' fractures, which had severed the nerve supply to the area of skin involved, has also been observed (Hoyt & Billson, 1976 ). Scriba (1981) recovered latent HSV-2 from FP skin, but not the DRG, of guinea-pigs infected with virus into the FP 10 days after surgical denervation. Recovery of virus from the peripheral regions may be due either to reactivation of virus latent within nervous tissue which subsequently travels via a nerve to the peripheral site, or to the presence of virus over a long period at peripheral sites, although these two possibilities are not mutually exclusive. We think it most unlikely that the input virus could persist either as such or in a slowly replicating form during the 3 months or more elapsing between inoculation and dissection. We suggest that the virus is capable of establishing a latent infection in the FP and, as neural cell bodies have never been described as located in the mouse FP, it follows that the latency is established in cells other than neurones. The observed difference in timing of reactivation from the FP and DRG may be a result of this. At present, we cannot exclude the possibility of mechanical trapping after reactivation but before release of virus from the FP, contributing to the observed difference in timing of virus release. We feel this alone is unlikely to lead to such a large and consistent difference as is observed. We are presently extending the study using immunofluorescence and in situ hybridization.
